Gazyva (obinutuzumab) - Roche, Biogen
Clinical characteristics of acute thrombocytopenia in newly diagnosed follicular lymphoma patients receiving obinutuzumab chemotherapy (PubMed, Zhonghua Xue Ye Xue Za Zhi) - Oct 10, 2026 - "Grade 1-2 thrombocytopenia may be observed during follow-up, whereas Grade 3-4 cases require close monitoring and active intervention. Identifying high-risk patients and implementing stratified management strategies can help optimize treatment safety." 
Journal • Retrospective data • Follicular Lymphoma • Hematological Malignancies • Lymphoma • Thrombocytopenia • B2M • CD4 • IL10
http://www.ncbi.nlm.nih.gov/pubmed/42851176
 
H N Tang; H Y Zhu; J X Zhou; J Y Li; L Fan; L Gao; S C Qin; Y L Kong; Y Xia
 
Oct 10, 2026
 
Prev Next